Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Midodrine Versus Albumin During Large-volume Paracentesis and Its Effect on Paracentesis Induced Circulatory Disturbance in Patients With Acute on Chronic Liver Failure - A Randomized Controlled Trial

NCT05240391 is registered in ClinicalTrials.gov with Asian Institute of Gastroenterology, India as lead sponsor.

NCT NCT05240391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Midodrine Versus Albumin During Large-volume Paracentesis and Its Effect on Paracentesis Induced Circulatory Disturbance in Patients With Acute on Chronic Liver Failure - A Randomized Controlled Trial
Lead sponsor
Asian Institute of Gastroenterology, India
Phase
Phase 3
Overall status
Completed
Start date
February 20, 2021
Completion date
May 5, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paracentesis-induced circulatory dysfunction